B. Lynne Parshall
CIK: 0001073385
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Sep 1, 2026CYTK
CYTOKINETICS INC
Sale(S)Direct5K shares at avg. $71.48$357K - Jun 24, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Options (Right to buy)
28K shares at avg. $4.08- - Jun 1, 2026CYTK
CYTOKINETICS INC
Sale(S)Direct5K shares at avg. $74.08$370K - May 27, 2026CYTK
CYTOKINETICS INC
Award(A)Direct2.9K shares- - Apr 15, 2026IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct4.5K shares at avg. $76.19$340K - Apr 15, 2026IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct534 shares at avg. $76.97$41K - Mar 2, 2026CYTK
CYTOKINETICS INC
Sale(S)Direct5K shares at avg. $61.21$306K - Feb 11, 2026IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct5K shares at avg. $82.72$414K - Nov 19, 2025CYTK
CYTOKINETICS INC
Sale(S)Direct5K shares at avg. $64.73$324K - Oct 15, 2025IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct5K shares at avg. $71.74$359K - Sep 2, 2025IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct10.8K shares at avg. $50.42$542K - Sep 2, 2025IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct9.3K shares at avg. $51.49$476K - Aug 6, 2025IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct400 shares at avg. $42.63$17K - Aug 6, 2025IONS
IONIS PHARMACEUTICALS INC
Sale(S)Direct4.6K shares at avg. $41.87$193K - Jul 15, 2025IONS
IONIS PHARMACEUTICALS INC
Exercise(M)Direct4.1K shares- - Jul 1, 2025IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectNon-Qualified Stock Option (right to buy)
11.5K shares- - Jul 1, 2025IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Unit
5.2K shares- - Jun 17, 2025FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
25K shares at avg. $4.79- - May 14, 2025CYTK
CYTOKINETICS INC
Award(A)Direct7.3K shares- - Sep 9, 2024CYTK
CYTOKINETICS INC
Sale(S)Direct5K shares at avg. $54.92$275K - Sep 9, 2024CYTK
CYTOKINETICS INC
Exercise(M)Direct5K shares at avg. $21.61$108K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  CYTK CYTOKINETICS INC | Sale(S) | 5,000 | $71.48 | $357,400 | Direct |
| Jun 24, 2026 |  FHTX Foghorn Therapeutics Inc. | Award(A) Stock Options (Right to buy) | 28,000 | $4.08 | - | Direct |
| Jun 1, 2026 | CYTK CYTOKINETICS INC | Sale(S) | 5,000 | $74.08 | $370,400 | Direct |
| May 27, 2026 | CYTK CYTOKINETICS INC | Award(A) | 2,851 | - | $0 | Direct |
| Apr 15, 2026 |  IONS IONIS PHARMACEUTICALS INC | Sale(S) | 4,466 | $76.19 | $340,265 | Direct |
| Apr 15, 2026 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 534 | $76.97 | $41,102 | Direct |
| Mar 2, 2026 | CYTK CYTOKINETICS INC | Sale(S) | 5,000 | $61.21 | $306,050 | Direct |
| Feb 11, 2026 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 5,000 | $82.72 | $413,588 | Direct |
| Nov 19, 2025 | CYTK CYTOKINETICS INC | Sale(S) | 5,000 | $64.73 | $323,650 | Direct |
| Oct 15, 2025 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 5,000 | $71.74 | $358,722 | Direct |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 10,750 | $50.42 | $542,015 | Direct |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 9,250 | $51.49 | $476,283 | Direct |
| Aug 6, 2025 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 400 | $42.63 | $17,051 | Direct |
| Aug 6, 2025 | IONS IONIS PHARMACEUTICALS INC | Sale(S) | 4,600 | $41.87 | $192,595 | Direct |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | Exercise(M) | 4,079 | - | - | Direct |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | Award(A) Non-Qualified Stock Option (right to buy) | 11,518 | - | - | Direct |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | Award(A) Restricted Stock Unit | 5,220 | - | - | Direct |
| Jun 17, 2025 | FHTX Foghorn Therapeutics Inc. | Award(A) Stock Option (right to buy) | 25,000 | $4.79 | - | Direct |
| May 14, 2025 | CYTK CYTOKINETICS INC | Award(A) | 7,333 | - | - | Direct |
| Sep 9, 2024 | CYTK CYTOKINETICS INC | Sale(S) | 5,000 | $54.92 | $274,600 | Direct |
| Sep 9, 2024 | CYTK CYTOKINETICS INC | Exercise(M) | 5,000 | $21.61 | $108,050 | Direct |
1-21 of 21 transactions
About PARSHALL B LYNNE
PARSHALL B LYNNE (SEC CIK 0001073385) files insider reports with the SEC as Director of CYTOKINETICS INC (CYTK), Director of Foghorn Therapeutics Inc. (FHTX) and Director of IONIS PHARMACEUTICALS INC (IONS).
Signal8 holds 16 ownership filings by PARSHALL B LYNNE, all Form 4s, filed between Sep 9, 2024 and Sep 1, 2026. Those filings report 21 transactions, from Sep 9, 2024 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PARSHALL B LYNNE's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by PARSHALL B LYNNE
- Sep 1, 2026: Open-market sale of CYTK shares (Form 4, code S).
- Jun 24, 2026: Grant or award of FHTX derivative securities (Form 4, code A).
- Jun 1, 2026: Open-market sale of CYTK shares (Form 4, code S).
- May 27, 2026: Grant or award of CYTK shares (Form 4, code A).
- Apr 15, 2026: Open-market sales of IONS shares (2 lines, Form 4, code S).
Other insiders filing for CYTOKINETICS INC (CYTK)
- Blum Robert I, President & CEO
- Wysenski Nancy, Director
- Kaye Edward M. MD, Director
- Harrington Robert Arthur, Director
- Daly James M, Director
- WIERENGA WENDELL, Director